Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
DexCare
AddedFeb 15, 2024
UpdatedJun 18, 2026
DexCare

DexCare

Series C

DexCare: An intelligent PaaS orchestrating digital health system demand and capacity.

HQ
Seattle, WA, US
Founded
2021
Overview
Compare
Fundraising
Employees

DexCare is a Platform-as-a-Service (PaaS) designed for health systems, aiming to intelligently manage digital demand and health system capacity across various lines of care. The platform optimizes the allocation of healthcare resources, ensuring efficient patient care and operational effectiveness.

DexCare has achieved significant impact by enhancing the efficiency of health systems and improving patient outcomes. It has garnered attention for its innovative approach to healthcare management, contributing to the digital transformation of the industry.

DexCare - Similar Companies

dxcare logo

dxcare

Xealth logo

Xealth

xealth.com

CareDash logo

CareDash

NexHealth logo

NexHealth

nexhealth.com

Doctible logo

Doctible

doctible.com

Clearstep logo

Clearstep

clearstep.health

CuraPatient logo

CuraPatient

curapatient.com

Dina logo

Dina

dinacare.com

Rx.Health logo

Rx.Health

rx.health

HealthBlox logo

HealthBlox

healthblox.care

Healthie logo

Healthie

gethealthie.com

Doctivity Health logo

Doctivity Health

careviso logo

careviso

careviso.com

HealthCareLove logo

HealthCareLove

CareStack logo

CareStack

carestack.com

DexCare - Quick Facts

Who are DexCare's competitors?

Companies similar to DexCare include dxcare, Xealth, CareDash and NexHealth.

When was DexCare founded?

DexCare was founded in 2021.

Where is DexCare's headquarters located?

DexCare's headquarters is located in Seattle, WA, US.

When was DexCare's last funding round?

DexCare's most recent funding round was for $75M (USD) in June 2023.

How much has DexCare raised to-date?

As of Jun 21, 2023, DexCare has raised a total of $145M (USD).

How many employees does DexCare have?

DexCare has 179 employees as of Feb 5, 2024.

DexCare - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Healthcare Platform
Tags
  • Healthcare
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software